The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Carbon emissions and non-biodegradable medical waste generation with alternative dosing strategies.
 
Sofia I Jacobson
No Relationships to Disclose
 
Alec Kacew
No Relationships to Disclose
 
Randall W. Knoebel
No Relationships to Disclose
 
Po-Hung Hsieh
No Relationships to Disclose
 
Mark J. Ratain
Stock and Other Ownership Interests - SAB Biotherapeutics; SAB Biotherapeutics
Honoraria - Emerson Lake Safety
Consulting or Advisory Role - Apotex; Aptevo Therapeutics; Arvinas; Ayala Pharmaceuticals; Bayer; Bluebird Bio; Cantex Pharmaceuticals; Eagle Pharmaceuticals; EMD Serono; EQRx; Genentech; Oncovalent Therapeutics
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Genentech/Roche (Inst); Incyte (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Provisional patent application for method of treating viral pneumonitis with low-dose tocilizumab (Inst); royalties related to UGT1A1 genotyping for irinotecan; royalties related to UGT1A1 genotyping for irinotecan (Inst)
Expert Testimony - Multiple generic companies (defendants in patent litigation)
Other Relationship - Credit Suisse; Optimal Cancer Care Alliance (OCCA); William Blair
 
Garth William Strohbehn
Patents, Royalties, Other Intellectual Property - Co-inventor of a filed patent held by the University of Chicago covering the use of low-dose tocilizumab in the treatment of viral infections. (Inst)